Naoya Kato, MSc
CEO & Representative Director, IDEC
![](https://eliquent.com/wp-content/uploads/2024/01/KATO_NAOYA-WEB-headshot-768x768.png)
JAPAN REGULATORY AFFAIRS
Mr. Kato has more than 30 years’ experience working at large multi-national pharmaceutical companies, including Roche and Amgen.
regulatory science for the development of global product development strategies. Mr. Kato achieved several successful globally-integrated programs involving Japan by leading global project teams through PMDA consultations and clarifying the regulatory requirements for Japanese submissions—including CTNs and Japanese NDAs—for global product development programs.